Rigel Pharmaceuticals (RIGL) Non-cash Items (2012 - 2025)

Rigel Pharmaceuticals' Non-cash Items history runs 14 years deep, the most recent figure standing at $3.2 million for Q3 2025.

• In Q3 2025, Non-cash Items rose 28.0% year-over-year to $3.2 million; the TTM figure through Sep 2025 stood at $3.2 million (up 28.0% YoY), while the FY2024 annual figure was $2.7 million, down 89.12% from the prior year.
• Non-cash Items was $3.2 million for Q3 2025 at Rigel Pharmaceuticals, down from $20.5 million in the prior quarter.
• In the past five years, Non-cash Items ranged from a high of $24.4 million in Q4 2023 to a low of $1.6 million in Q4 2022.
• Historically, Non-cash Items has averaged $7.9 million across 5 years, with a median of $5.0 million in 2022.
• The sharpest annual moves came in 2023 and 2024: Non-cash Items jumped 1418.93% in 2023, then slumped 89.12% in 2024.
• A 5-year view of Non-cash Items shows it stood at $6.8 million in 2021, then sank by 76.44% to $1.6 million in 2022, then surged by 1418.93% to $24.4 million in 2023, then plunged by 89.12% to $2.7 million in 2024, then climbed by 20.62% to $3.2 million in 2025.
• The last three Non-cash Items figures came in at $3.2 million (Q3 2025), $20.5 million (Q2 2025), and $3.5 million (Q1 2025), per Business Quant data.